ArticleKidney medicine2026

Efficacy of Low-Dose Tolvaptan for Treatment of Profound Hyponatremia in Syndrome of Inappropriate Antidiuresis (SIAD): The EFFLUX-FLUID TRIAL.

Narongchai Jaiyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.